RHYTHM PHARMACEUTICALS, INC. (RYTM) Shareholders’ equity 2016–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) shareholders’ equity at each fiscal year-end, per SEC filings.
$139.1MFY2025 · since FY2016: -$32.7M → $139.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $139.1M | +540.0% |
| FY2024 | $21.7M | -87.2% |
| FY2023 | $169.8M | -35.8% |
| FY2022 | $264.3M | -7.0% |
| FY2021 | $284.2M | +70.6% |
| FY2020 | $166.5M | -40.7% |
| FY2019 | $281.0M | +14.1% |
| FY2018 | $246.3M | +70.1% |
| FY2017 | $144.8M | +542.7% |
| FY2016 | -$32.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice